03/26/2024
- Large advisory firm
18
4
SEC, Approved, 7/31/1998
237,342,852 -21.27%
237,342,852 -21.27%
237,720,571 -21.15%
79,114,284 -21.27%
NO
3
212 xxxxxxx
1 Day FDMT -3.62% DJIA 1.39% S&P Mid Cap 400 2.32% Health Care/Life Sciences 1.99% John F. Milligan, 58 Executive Chairman 4D Molecular Therapeutics, Inc., Biotechnology Innovation Organization ...
Wall Street JournalFund Type | Count | GAV |
---|---|---|
Hedge Fund | 1 | $197,078,120 |
Other Private Fund | 2 | $40,642,451 |
Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | # funds | |
---|---|---|---|---|---|---|---|---|---|---|---|
UNIMAR FINANCIAL SERVICES, LLC | 70.7m | - | - | - | - | - | 121.3m | 192.0m | 229.2m | 6 | |
WESTROCK ASSET MANAGEMENT, LLC | 405.8m | - | - | - | - | - | 33.1m | 439.0m | 416.8m | 3 | |
SQN INVESTORS LP | 247.3m | - | - | - | - | - | 31.9m | 279.1m | 279.1m | 3 | |
BALEEN CAPITAL MANAGEMENT LLC | 83.1m | - | - | - | - | - | 29.4m | 112.5m | 112.5m | 3 | |
CALLODINE CAPITAL MANAGEMENT, LP | 443.1m | - | - | - | - | - | 76.2m | 519.3m | 607.4m | 2 | |
IMARA ASSET MANAGEMENT LIMITED | 3.8m | - | - | - | - | - | 38.9m | 42.7m | 42.8m | 3 | |
ARCUS INVESTMENT ASIA LIMITED | - | - | - | - | - | - | - | - | - | - | |
UTXO MANAGEMENT GP, LLC | - | - | - | - | - | - | - | - | - | - | |
JENEQ MANAGEMENT LP | - | - | - | - | - | - | - | - | - | - | |
RAGING CAPITAL MANAGEMENT, LLC. | 38.6m | - | - | - | - | - | 3.0m | 41.6m | - | 3 |